The DOI matches its Crossref record; 283 of the 283 references it cites were found in a registry or an index.
The Multifaceted Role of Curcumin in Cancer Prevention and Treatment
Open accessAbstract
Despite significant advances in treatment modalities over the last decade, neither the incidence of the disease nor the mortality due to cancer has altered in the last thirty years. Available anti-cancer drugs exhibit limited efficacy, associated with severe side effects, and are also expensive. Thus identification of pharmacological agents that do not have these disadvantages is required. Curcumin, a polyphenolic compound derived from turmeric (Curcumin longa), is one such agent that has been extensively studied over the last three to four decades for its potential anti-inflammatory and/or anti-cancer effects. Curcumin has been found to suppress initiation, progression, and metastasis of a variety of tumors. These anti-cancer effects are predominantly mediated through its negative regulation of various transcription factors, growth factors, inflammatory cytokines, protein kinases, and other oncogenic molecules. It also abrogates proliferation of cancer cells by arresting them at different phases of the cell cycle and/or by inducing their apoptosis. The current review focuses on the diverse molecular targets modulated by curcumin that contribute to its efficacy against various human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Wang, Z., Zhang, Y., Banerjee, S., Li, Y., & Sarkar, F. H. (2006) · Cancer · doi:10.1002/cncr.21904 · Cited by 263
RetractedCurcumin inhibits lung cancer progression and metastasis through induction of FOXO1
Li, Z.-C., Zhang, L., Wang, H., Ma, J., & Sun, J. (2013) · Tumor Biology · doi:10.1007/s13277-013-1013-7 · Cited by 42
RetractedCurcumin Potentiates Rhabdomyosarcoma Radiosensitivity by Suppressing NF-κB Activity
Orr, W. S., Denbo, J. W., Saab, K. R., Ng, C. Y., Wu, J., Li, K., Garner, J. M., Morton, C. L., Du, Z., Pfeffer, L. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0051309 · Cited by 28
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Calcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 1×
“STAT3 can be activated by IL-6, EGFR, PDGF, leukemia inhibitory factor (LIF), oncostatin M, and the ciliary neurotrophic factor (CNTF) family of cytokines, which are all known to mediate their signal through the gp130 protein [130–133].”
BackgroundWnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325
Seger, R., & Krebs, E. G. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.9.7601337 · Cited by 3,602
Karin, M., Liu, Z.-G., & Zandi, E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80068-3 · Cited by 2,893
Roux, P. P., & Blenis, J. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.2.320-344.2004 · Cited by 2,490
AP-1: a double-edged sword in tumorigenesis
Eferl, R., & Wagner, E. F. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1209 · Cited by 2,242
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2013) · The AAPS Journal · doi:10.1208/s12248-012-9432-8 · Cited by 2,110
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
CURCUMIN: THE INDIAN SOLID GOLD
Aggarwal, B. B., Sundaram, C., Malani, N., & Ichikawa, H. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_1 · Cited by 1,647
Sugarman, B. J., Aggarwal, B. B., Hass, P. E., Figari, I. S., Palladino, M. A., & Shepard, H. M. (1985) · Science · doi:10.1126/science.3933111 · Cited by 1,580
Dose escalation of a curcuminoid formulation
Lao, C. D., Ruffin, M. T., Normolle, D., Heath, D. D., Murray, S. I., Bailey, J. M., Boggs, M. E., Crowell, J., Rock, C. L., & Brenner, D. E. (2006) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-6-10 · Cited by 1,394
ANTIOXIDANT AND ANTI-INFLAMMATORY PROPERTIES OF CURCUMIN
Menon, V. P., & Sudheer, A. R. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_3 · Cited by 1,392
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
Singh, S., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24995 · Cited by 1,386
Ammon, H., & Wahl, M. (1991) · Planta Medica · doi:10.1055/s-2006-960004 · Cited by 1,347
Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
Dhillon, N., Aggarwal, B. B., Newman, R. A., Wolff, R. A., Kunnumakkara, A. B., Abbruzzese, J. L., Ng, C. S., Badmaev, V., & Kurzrock, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0024 · Cited by 1,331
Inflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Self-citationPhase I Clinical Trial of Oral Curcumin
Sharma, R. A., Euden, S. A., Platton, S. L., Cooke, D. N., Shafayat, A., Hewitt, H. R., Marczylo, T. H., Morgan, B., Hemingway, D., Plummer, S. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0744 · Cited by 1,257
Aggarwal, B. B., & Sung, B. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.11.002 · Cited by 1,140
Nitric Oxide Scavenging by Curcuminoids
Sreejayan, & Rao, M. N. A. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06761.x · Cited by 1,135
Curcumin and cancer: An “old-age” disease with an “age-old” solution
Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.025 · Cited by 1,132
Kunnumakkara, A. B., Anand, P., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.009 · Cited by 1,073
Wilken, R., Veena, M. S., Wang, M. B., & Srivatsan, E. S. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-12 · Cited by 1,066
Molecular cloning and expression of an IL-6 signal transducer, gp130
Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., & Kishimoto, T. (1990) · Cell · doi:10.1016/0092-8674(90)90411-7 · Cited by 1,039
BALOGUN, E., HOQUE, M., GONG, P., KILLEEN, E., GREEN, C. J., FORESTI, R., ALAM, J., & MOTTERLINI, R. (2003) · Biochemical Journal · doi:10.1042/bj20021619 · Cited by 1,036
Akira, S., Nishio, Y., Inoue, M., Wang, X.-J., We, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., & Kishimoto, T. (1994) · Cell · doi:10.1016/0092-8674(94)90235-6 · Cited by 1,019
Differentiation and reversal of malignant changes in colon cancer through PPARγ
Sarraf, P., Mueller, E., Jones, D., King, F. J., DeAngelo, D. J., Partridge, J. B., Holden, S. A., Chen, L. B., Singer, S., Fletcher, C., et al. (1998) · Nature Medicine · doi:10.1038/2030 · Cited by 988
Aggarwal, B. B., Gupta, S. C., & Kim, J. H. (2012) · Blood · doi:10.1182/blood-2011-04-325225 · Cited by 877
The many ways of Wnt in cancer
Polakis, P. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.007 · Cited by 866
Curcumin, a component of golden spice: From bedside to bench and back
Prasad, S., Gupta, S. C., Tyagi, A. K., & Aggarwal, B. B. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.04.004 · Cited by 858
Naksuriya, O., Okonogi, S., Schiffelers, R. M., & Hennink, W. E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.090 · Cited by 841
Jobin, C., Bradham, C. A., Russo, M. P., Juma, B., Narula, A. S., Brenner, D. A., & Sartor, R. B. (1999) · PubMed · Cited by 718
Potential anticancer activity of turmeric (Curcuma longa)
Kuttan, R., Bhanumathy, P., Nirmala, K., & George, M. C. (1985) · Cancer Letters · doi:10.1016/0304-3835(85)90159-4 · Cited by 687
Jobin, C., Bradham, C. A., Russo, M. P., Juma, B., Narula, A. S., Brenner, D. A., & Sartor, R. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.6.3474 · Cited by 681
Multitargeting by curcumin as revealed by molecular interaction studies
Gupta, S. C., Prasad, S., Kim, J. H., Patchva, S., Webb, L. J., Priyadarsini, I. K., & Aggarwal, B. B. (2011) · Natural Product Reports · doi:10.1039/c1np00051a · Cited by 669
Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
Siveen, K. S., Sikka, S., Surana, R., Dai, X., Zhang, J., Kumar, A. P., Tan, B. K. H., Sethi, G., & Bishayee, A. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.12.005 · Cited by 634
Self-citationPlummer, S. M., Holloway, K. A., Manson, M. M., Munks, R. J., Kaptein, A., Farrow, S., & Howells, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202980 · Cited by 628
Aggarwal, B. B., Shishodia, S., Takada, Y., Banerjee, S., Newman, R. A., Bueso-Ramos, C. E., & Price, J. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1192 · Cited by 584
Heger, M., van Golen, R. F., Broekgaarden, M., & Michel, M. C. (2014) · Pharmacological Reviews · doi:10.1124/pr.110.004044 · Cited by 576
Shehzad, A., Wahid, F., & Lee, Y. S. (2010) · Archiv der Pharmazie · doi:10.1002/ardp.200900319 · Cited by 542
Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 Pathway
Hayes, J. D., McMahon, M., Chowdhry, S., & Dinkova-Kostova, A. T. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3221 · Cited by 539
Aoki, H., Takada, Y., Kondo, S., Sawaya, R., Aggarwal, B. B., & Kondo, Y. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.033167 · Cited by 523
Bharti, A. C., Donato, N., & Aggarwal, B. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3863 · Cited by 508
Grandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., Zeng, Q., Pitt, A. S., & Tweardy, D. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3785 · Cited by 507
Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia
Carroll, R. E., Benya, R. V., Turgeon, D. K., Vareed, S., Neuman, M., Rodriguez, L., Kakarala, M., Carpenter, P. M., McLaren, C., Meyskens, F. L., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0098 · Cited by 503
Garcea, G., Berry, D. P., Jones, D. J. L., Singh, R., Dennison, A. R., Farmer, P. B., Sharma, R. A., Steward, W. P., & Gescher, A. J. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.120.14.1 · Cited by 494
Carlesso, N., Frank, D. A., & Griffin, J. D. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.811 · Cited by 483
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
Bar-Sela, G., Epelbaum, R., & Schaffer, M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790149738 · Cited by 479
NF-κB addiction and its role in cancer: ‘one size does not fit all’
Chaturvedi, M. M., Sung, B., Yadav, V. R., Kannappan, R., & Aggarwal, B. B. (2011) · Oncogene · doi:10.1038/onc.2010.566 · Cited by 473
Brouet, I., & Ohshima, H. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1076 · Cited by 471
Shishodia, S., Amin, H. M., Lai, R., & Aggarwal, B. B. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.043 · Cited by 459
TNF: A master switch for inflammation to cancer
Sethi, G. (2008) · Frontiers in Bioscience · doi:10.2741/3066 · Cited by 458
Self-citationInnovative Preparation of Curcumin for Improved Oral Bioavailability
Sasaki, H., Sunagawa, Y., Takahashi, K., Imaizumi, A., Fukuda, H., Hashimoto, T., Wada, H., Katanasaka, Y., Kakeya, H., Fujita, M., et al. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.660 · Cited by 450
Combination Treatment With Curcumin and Quercetin of Adenomas in Familial Adenomatous Polyposis
Cruz–Correa, M., Shoskes, D. A., Sanchez, P., Zhao, R., Hylind, L. M., Wexner, S. D., & Giardiello, F. M. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.020 · Cited by 434
Curcumin induces apoptosis in human breast cancer cells through p53‐dependent Bax induction
Choudhuri, T., Pal, S., Agwarwal, M. L., Das, T., & Sa, G. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02292-5 · Cited by 429
Garcea, G., Jones, D. J. L., Singh, R., Dennison, A. R., Farmer, P. B., Sharma, R. A., Steward, W. P., Gescher, A. J., & Berry, D. P. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601623 · Cited by 425
Nuclear Factor-κB Activation: From Bench to Bedside
Sethi, G., Sung, B., & Aggarwal, B. B. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-196 · Cited by 417
Self-citationRole of Curcumin in Cancer Therapy
Shishodia, S., Chaturvedi, M. M., & Aggarwal, B. B. (2007) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2007.04.001 · Cited by 413
Preliminary study on antirheumatic activity of curcumin (diferuloyl methane).
Deodhar, S. D., Sethi, R., & Srimal, R. C. (1980) · PubMed · Cited by 410
Transcription Factors in Liver Development, Differentiation, and Regeneration
Costa, R. H., Kalinichenko, V. V., Holterman, A.-X. L., & Wang, X. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.034 · Cited by 409
Inflammation and cancer: how friendly is the relationship for cancer patients?
Aggarwal, B. B., & Gehlot, P. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.020 · Cited by 405
Bayet-Robert, M., Kwiatowski, F., Leheurteur, M., Gachon, F., Planchat, E., Abrial, C., Mouret-Reynier, M.-A., Durando, X., Barthomeuf, C., & Chollet, P. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.1.10392 · Cited by 399
Kanai, M., Yoshimura, K., Asada, M., Imaizumi, A., Suzuki, C., Matsumoto, S., Nishimura, T., Mori, Y., Masui, T., Kawaguchi, Y., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1470-2 · Cited by 399
Chan, M. M.-Y., Huang, H.-I., Fenton, M. R., & Fong, D. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00114-2 · Cited by 398
Li, F., & Sethi, G. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.002 · Cited by 398
Self-citationAGGARWAL, B. B., SETHI, G., AHN, K. S., SANDUR, S. K., PANDEY, M. K., KUNNUMAKKARA, A. B., SUNG, B., & ICHIKAWA, H. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.063 · Cited by 398
Self-citationNrf2 the rescue: Effects of the antioxidative/electrophilic response on the liver
Klaassen, C. D., & Reisman, S. A. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.01.013 · Cited by 396
Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin
Chen, Y.-R., & Tan, T.-H. (1998) · Oncogene · doi:10.1038/sj.onc.1201941 · Cited by 392
Bush, J. A., Cheung, K.-J. J., & Li, G. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5381 · Cited by 385
Telomerase directly regulates NF-κB-dependent transcription
Ghosh, A., Saginc, G., Leow, S. C., Khattar, E., Shin, E. M., Yan, T. D., Wong, M., Zhang, Z., Li, G., Sung, W.-K., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2621 · Cited by 378
Signaling mechanisms through gp130: A model of the cytokine system
Hirano, T., Nakajima, K., & Hibi, M. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)80005-1 · Cited by 370
Jaiswal, A. S., Marlow, B. P., Gupta, N., & Narayan, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205947 · Cited by 363
Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein
Peeper, D. S., Upton, T. M., Ladha, M. H., Neuman, E., Zalvide, J., Bernards, R., DeCaprio, J. A., & Ewen, M. E. (1997) · Nature · doi:10.1038/386177a0 · Cited by 357
Mukhopadhyay, A., Banerjee, S., Stafford, L. J., Xia, C., Liu, M., & Aggarwal, B. B. (2002) · Oncogene · doi:10.1038/sj.onc.1206048 · Cited by 353
Emerging roles of ATF2 and the dynamic AP1 network in cancer
Lopez-Bergami, P., Lau, E., & Ronai, Z. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2681 · Cited by 350
Bengmark, S. (2006) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860710603000145 · Cited by 345
Multifaceted link between cancer and inflammation
Sethi, G., Shanmugam, M. K., Ramachandran, L., Kumar, A. P., & Tergaonkar, V. (2012) · Bioscience Reports · doi:10.1042/bsr20100136 · Cited by 333
Self-citationChoudhuri, T., Pal, S., Das, T., & Sa, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410670200 · Cited by 321
Bharti, A. C., Shishodia, S., Reuben, J. M., Weber, D., Alexanian, R., Raj-Vadhan, S., Estrov, Z., Talpaz, M., & Aggarwal, B. B. (2004) · Blood · doi:10.1182/blood-2003-06-2151 · Cited by 318
Chronic adipose tissue inflammation: all immune cells on the stage
Cildir, G., Akıncılar, S. C., & Tergaonkar, V. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.05.001 · Cited by 317
Weber-Nordt, R., Egen, C., Wehinger, J., Ludwig, W., Gouilleux-Gruart, V, Mertelsmann, R., & Finke, J. (1996) · Blood · doi:10.1182/blood.v88.3.809.809 · Cited by 314
Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols
Gupta, S. C., Tyagi, A. K., Deshmukh-Taskar, P., Hinojosa, M., Prasad, S., & Aggarwal, B. B. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.06.006 · Cited by 313
Chen, A., Xu, J., & Johnson, A. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209019 · Cited by 301
Dhandapani, K. M., Mahesh, V. B., & Brann, D. W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04633.x · Cited by 298
Turmeric and Curcumin as Topical Agents in Cancer Therapy
Kuttan, R., Sudheeran, P. C., & Josph, C. D. (1987) · Tumori Journal · doi:10.1177/030089168707300105 · Cited by 293
Shishodia, S., Potdar, P., Gairola, C. G., & Aggarwal, B. B. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg078 · Cited by 292
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
Epelbaum, R., Schaffer, M., Vizel, B., Badmaev, V., & Bar-Sela, G. (2010) · Nutrition and Cancer · doi:10.1080/01635581.2010.513802 · Cited by 282
Subramaniam, A., Shanmugam, M. K., Perumal, E., Li, F., Nachiyappan, A., Dai, X., Swamy, S. N., Ahn, K. S., Kumar, A. P., Tan, B. K. H., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.10.002 · Cited by 278
Self-citationWeir, N. M., Selvendiran, K., Kutala, V. K., Tong, L., Vishwanath, S., Rajaram, M., Tridandapani, S., Anant, S., & Kuppusamy, P. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.2.3577 · Cited by 275
NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy
Shen, H.-M., & Tergaonkar, V. (2009) · Apoptosis · doi:10.1007/s10495-009-0315-0 · Cited by 275
Li, M., Zhang, Z., Hill, D. L., Wang, H., & Zhang, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3066 · Cited by 274
Upregulation of p53 Expression in Patients with Colorectal Cancer by Administration of Curcumin
He, Z.-Y., Shi, C.-B., Wen, H., Li, F.-L., Wang, B.-L., & Wang, J. (2011) · Cancer Investigation · doi:10.3109/07357907.2010.550592 · Cited by 274
One size does not fit all: The oligomeric states of αB crystallin
Delbecq, S. P., & Klevit, R. E. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.021 · Cited by 263
Curcumin and Liver Cancer: A Review
S. Darvesh, A., B. Aggarwal, B., & Bishayee, A. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112798868791 · Cited by 263
New Perspectives of Curcumin in Cancer Prevention
Park, W., Amin, A. R. M. R., Chen, Z. G., & Shin, D. M. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0410 · Cited by 260
Kanai, M., Imaizumi, A., Otsuka, Y., Sasaki, H., Hashiguchi, M., Tsujiko, K., Matsumoto, S., Ishiguro, H., & Chiba, T. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1673-1 · Cited by 258
Telomerase: central regulator of all of the hallmarks of cancer
Low, K. C., & Tergaonkar, V. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.07.001 · Cited by 257
Lin, S.-S., Lai, K.-C., Hsu, S.-C., Yang, J.-S., Kuo, C.-L., Lin, J.-P., Ma, Y.-S., Wu, C.-C., & Chung, J.-G. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.04.037 · Cited by 254
Molecular mechanisms of curcumin action: Signal transduction
Shehzad, A., & Lee, Y. S. (2013) · BioFactors · doi:10.1002/biof.1065 · Cited by 248
Divya, C. S., & Pillai, M. R. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20170 · Cited by 248
Khor, T. O., Huang, Y., Wu, T.-Y., Shu, L., Lee, J., & Kong, A.-N. T. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.065 · Cited by 245
Curcumin Inhibits the Proteasome Activity in Human Colon Cancer Cells In vitro and In vivo
Milacic, V., Banerjee, S., Landis-Piwowar, K. R., Sarkar, F. H., Majumdar, A. P. N., & Dou, Q. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6246 · Cited by 243
Philip, S., & Kundu, G. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207309200 · Cited by 240
Kumar, A., Dhawan, S., Hardegen, N. J., & Aggarwal, B. B. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00557-1 · Cited by 238
Self-citationShanmugam, M. K., Kannaiyan, R., & Sethi, G. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.523502 · Cited by 235
Self-citationEggler, A. L., Gay, K. A., & Mesecar, A. D. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700249 · Cited by 235
Curcumin attenuation of acute adriamycin myocardial toxicity in rats
Venkatesan, N. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701877 · Cited by 235
Shankar, S., & Srivastava, R. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.4.905 · Cited by 235
Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells
Shi, M., Cai, Q., Yao, L., Mao, Y., Ming, Y., & Ouyang, G. (2006) · Cell Biology International · doi:10.1016/j.cellbi.2005.10.024 · Cited by 228
Shakibaei, M., Mobasheri, A., Lueders, C., Busch, F., Shayan, P., & Goel, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057218 · Cited by 226
Shehzad, A., Lee, J., & Lee, Y. S. (2013) · BioFactors · doi:10.1002/biof.1068 · Cited by 224
Yang, C.-L., Liu, Y.-Y., Ma, Y.-G., Xue, Y.-X., Liu, D.-G., Ren, Y., Liu, X.-B., Li, Y., & Li, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037960 · Cited by 220
Prusty, B. K., & Das, B. C. (2005) · International Journal of Cancer · doi:10.1002/ijc.20668 · Cited by 218
Hepatoprotection via the IL-6/Stat3 pathway
Taub, R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19974 · Cited by 217
Curcumin Induces a p53-Dependent Apoptosis in Human Basal Cell Carcinoma Cells
Jee, S.-H., Shen, S.-C., Kuo, M.-L., Tseng, C.-R., & Chiu, H.-C. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00352.x · Cited by 215
Bachmeier, B., Nerlich, A., Iancu, C., Cilli, M., Schleicher, E., Vené, R., Dell'Eva, R., Jochum, M., Albini, A., & Pfeffer, U. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000099202 · Cited by 212
Antihepatotoxic Principles of Curcuma longa Rhizomes
Kiso, Y., Suzuki, Y., Watanabe, N., Oshima, Y., & Hikino, H. (1983) · Planta Medica · doi:10.1055/s-2007-969845 · Cited by 211
Patel, B. B., Sengupta, R., Qazi, S., Vachhani, H., Yu, Y., Rishi, A. K., & Majumdar, A. P. N. (2008) · International Journal of Cancer · doi:10.1002/ijc.23097 · Cited by 208
MODULATION OF TRANSCRIPTION FACTORS BY CURCUMIN
Shishodia, S., Singh, T., & Chaturvedi, M. M. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_4 · Cited by 207
Anti-thrombotic effect of curcumin
Srivastava, R., Dikshit, M., Srimal, R. C., & Dhawan, B. N. (1985) · Thrombosis Research · doi:10.1016/0049-3848(85)90276-2 · Cited by 203
Functional proteomics to dissect tyrosine kinase signalling pathways in cancer
Kolch, W., & Pitt, A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2900 · Cited by 200
Kunnumakkara, A. B., Diagaradjane, P., Anand, P., Kuzhuvelil, H. B., Deorukhkar, A., Gelovani, J., Guha, S., Krishnan, S., & Aggarwal, B. B. (2009) · International Journal of Cancer · doi:10.1002/ijc.24593 · Cited by 199
Roles of NF-κB in health and disease: mechanisms and therapeutic potential
Wong, E. T., & Tergaonkar, V. (2009) · Clinical Science · doi:10.1042/cs20080502 · Cited by 196
McNally, S., Harrison, E., Ross, J., Garden, O., & Wigmore, S. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.1.165 · Cited by 192
Curcumin attenuates DNB-induced murine colitis
Salh, B., Assi, K., Templeman, V., Parhar, K., Owen, D., Gómez-Muñoz, A., & Jacobson, K. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00449.2002 · Cited by 192
Chen, J., Tang, X. Q., Zhi, J. L., Cui, Y., Yu, H. M., Tang, E. H., Sun, S. N., Feng, J. Q., & Chen, P. X. (2006) · Apoptosis · doi:10.1007/s10495-006-6715-5 · Cited by 184
Rai, B., Kaur, J., Jacobs, R., & Singh, J. (2010) · Journal of Oral Science · doi:10.2334/josnusd.52.251 · Cited by 184
Sandur, S. K., Deorukhkar, A., Pandey, M. K., Pabón, A. M., Shentu, S., Guha, S., Aggarwal, B. B., & Krishnan, S. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.06.034 · Cited by 183
Killian, P. H., Kronski, E., Michalik, K. M., Barbieri, O., Astigiano, S., Sommerhoff, C. P., Pfeffer, U., Nerlich, A. G., & Bachmeier, B. E. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs312 · Cited by 183
Ide, H., Tokiwa, S., Sakamaki, K., Nishio, K., Isotani, S., Muto, S., Hama, T., Masuda, H., & Horie, S. (2010) · The Prostate · doi:10.1002/pros.21147 · Cited by 181
Switching on kinases: oncogenic activation of BRAF and the PDGFR family
Dibb, N. J., Dilworth, S. M., & Mol, C. D. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1434 · Cited by 179
Jutooru, I., Chadalapaka, G., Lei, P., & Safe, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095240 · Cited by 178
Woo, M.-S., Jung, S.-H., Kim, S.-Y., Hyun, J.-W., Ko, K.-H., Kim, W.-K., & Kim, H.-S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.174 · Cited by 176
WIP1 phosphatase is a negative regulator of NF-κB signalling
Chew, J., Biswas, S., Shreeram, S., Humaidi, M., Wong, E. T., Dhillion, M. K., Teo, H., Hazra, A., Fang, C. C., López-Collazo, E., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1873 · Cited by 172
Liu, E., Wu, J., Cao, W., Zhang, J., Liu, W., Jiang, X., & Zhang, X. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9421-4 · Cited by 172
Potential pharmacological control of the NF-κB pathway
Sethi, G., & Tergaonkar, V. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.03.004 · Cited by 171
Self-citationTumour necrosis factor-α mediates tumour promotion via a PKCα- and AP-1-dependent pathway
Arnott, C. H., Scott, K. A., Moore, R. J., Hewer, A., Phillips, D. H., Parker, P., Balkwill, F. R., & Owens, D. M. (2002) · Oncogene · doi:10.1038/sj.onc.1205588 · Cited by 165
Rushworth, S. A., Ogborne, R. M., Charalambos, C. A., & O’Connell, M. A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.065 · Cited by 165
Tu, S. P., Jin, H., Shi, J. D., Zhu, L. M., Suo, Y., Lu, G., Liu, A., Wang, T. C., & Yang, C. S. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0247 · Cited by 165
Zanotto-Filho, A., Braganhol, E., Edelweiss, M. I., Behr, G. A., Zanin, R., Schröder, R., Simões-Pires, A., Battastini, A. M. O., & Moreira, J. C. F. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.02.015 · Cited by 164
Prasad, C. P., Rath, G., Mathur, S., Bhatnagar, D., & Ralhan, R. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.06.012 · Cited by 161
Senft, C., Polacin, M., Priester, M., Seifert, V., Kögel, D., & Weissenberger, J. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-491 · Cited by 160
Chen, A., & Xu, J. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00209.2004 · Cited by 158
Lee, J. C., Kinniry, P. A., Arguiri, E., Serota, M., Kanterakis, S., Chatterjee, S., Solomides, C., Javvadi, P., Koumenis, C., Cengel, K. A., et al. (2010) · Radiation Research · doi:10.1667/rr1522.1 · Cited by 154
Lev‐Ari, S., Starr, A., Vexler, A. M., Karaush, V., Loew, V., Greif, J., Fenig, E., Aderka, D., & Ben‐Yosef, R. (2006) · PubMed · Cited by 151
Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways
Dey, A., Tergaonkar, V., & Lane, D. P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2759 · Cited by 151
Sung, B., Kunnumakkara, A. B., Sethi, G., Anand, P., Guha, S., & Aggarwal, B. B. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0905 · Cited by 150
Self-citationWatson, J. L., Greenshields, A. L., Hill, R., Hilchie, A. L., Lee, P. W. K., Giacomantonio, C. A., & Hoskin, D. W. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20571 · Cited by 148
Ramachandran, L., Manu, K. A., Shanmugam, M. K., Feng, L., Siveen, K. S., Vali, S., Kapoor, S., Abbasi, T., Surana, R., Smoot, D. T., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.388702 · Cited by 147
Self-citationZheng, M., Ekmekçioglu, S., Walch, E. T., Tang, C., & Grimm, E. A. (2004) · Melanoma Research · doi:10.1097/01.cmr.0000129374.76399.19 · Cited by 144
Mackenzie, G. G., Queisser, N., Wolfson, M. L., Fraga, C. G., Adamo, A. M., & Oteiza, P. I. (2008) · International Journal of Cancer · doi:10.1002/ijc.23477 · Cited by 144
Balachandran, V., Antony, J., Haritha, N. H., Puliyappadamba, V. T., Saikia, M., Narayanan, S. S., Bevin, A., & Anto, R. J. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.26 · Cited by 142
Polytarchou, C., Hatziapostolou, M., & Papadimitriou, Ε. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505120200 · Cited by 142
Weissenberger, J., Priester, M., Bernreuther, C., Rakel, S., Glatzel, M., Seifert, V., & Kögel, D. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0446 · Cited by 142
Saydmohammed, M., Joseph, D., & Syed, V. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22558 · Cited by 142
Role of Epigenetics in Inflammation-Associated diseases
Shanmugam, M. K., & Sethi, G. (2013) · Subcellular Biochemistry · doi:10.1007/978-94-007-4525-4_27 · Cited by 141
Self-citationMechanisms of action of novel agents for prostate cancer chemoprevention
Singh, R. P., & Agarwal, R. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01126 · Cited by 141
Prakobwong, S., Gupta, S. C., Kim, J. H., Sung, B., Pinlaor, P., Hiraku, Y., Wongkham, S., Sripa, B., Pinlaor, S., & Aggarwal, B. B. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr032 · Cited by 141
Ryu, M., Cho, M., Song, J., Yun, Y., Choi, I., Kim, D., Park, B., & Oh, S. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.171 · Cited by 140
Chen, B., Zhang, Y., Wang, Y., Rao, J., Jiang, X., & Xu, Z. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.01.009 · Cited by 140
Leow, P., Tian, Q., Ong, Z. Y., Yang, Z., & Ee, P. L. R. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9311-z · Cited by 139
Lin, L., Ke, Y.-F., Ko, Y.-C., & Lin, J. (1998) · Oncology · doi:10.1159/000011876 · Cited by 137
Lee, J., Lee, Y.-M., Chang, G., Yu, S., Hsieh, W.-Y., Chen, J. J. W., Chen, H., & Yang, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023756 · Cited by 137
ANTITUMOR, ANTI-INVASION, AND ANTIMETASTATIC EFFECTS OF CURCUMIN
Kuttan, G., Kumar, K. B. H., Guruvayoorappan, C., & Kuttan, R. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-46401-5_6 · Cited by 135
Liontas, A., & Yeger, H. (2004) · PubMed · Cited by 132
The inhibitory mechanism of curcumin and its derivative against β‐catenin/Tcf signaling
Park, C. H., Hahm, E., Park, S., Kim, H.-K., & Yang, C. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.013 · Cited by 131
NRF2, cancer and calorie restriction
Martín‐Montalvo, A., Villalba, J. M., Navas, P., & de Cabo, R. (2010) · Oncogene · doi:10.1038/onc.2010.492 · Cited by 130
Hour, T., Chen, J., Huang, C., Guan, J., Lu, S., & Pu, Y. (2002) · The Prostate · doi:10.1002/pros.10089 · Cited by 130
Su, C., Chen, G. W., Lin, J. G., Wu, L. T., & Chung, J. (2006) · PubMed · Cited by 129
Saw, C. L. L., Huang, Y. S., & Kong, A. T. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.030 · Cited by 128
Song, G., Mao, Y., Cai, Q., Yao, L., Ouyang, G., & Bao, S. D. (2005) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2005001200007 · Cited by 127
Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line
Yodkeeree, S., Ampasavate, C., Sung, B., Aggarwal, B. B., & Limtrakul, P. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.052 · Cited by 125
Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer
Alexandrow, M. G., Song, L., Altiok, S., Gray, J., Haura, E. B., & Kumar, N. B. (2011) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e32834ef194 · Cited by 125
Kim, S. G., Veena, M. S., Basak, S. K., Han, E., Tajima, T. L., Gjertson, D. W., Starr, J. M., Eidelman, O., Pollard, H. B., Srivastava, M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1272 · Cited by 124
Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma
Shahab Uddin, M. S., Hussain, A. R., Manogaran, P. S., Al‐Hussein, K., Platanias, L. C., Gutiérrez, M. I., & Bhatia, K. G. (2005) · Oncogene · doi:10.1038/sj.onc.1208864 · Cited by 123
Ghosh, A. K., Kay, N. E., Secreto, C. R., & Shanafelt, T. D. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1511 · Cited by 123
Nuclear Factor-Kappa B: From Clone to Clinic
Ahn, K., Sethi, G., & Aggarwal, B. B. (2007) · Current Molecular Medicine · doi:10.2174/156652407782564363 · Cited by 122
Self-citationBobrovnikova-Marjon, E. V., Marjon, P., Barbash, O., Jagt, D. L. V., & Abcouwer, S. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0682 · Cited by 121
Targeting TNF for Treatment of Cancer and Autoimmunity
Sethi, G., Sung, B., Kunnumakkara, A. B., & Aggarwal, B. B. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-89520-8_3 · Cited by 119
Self-citationGlienke, W., Maute, L., Wicht, J., & Bergmann, L. (2009) · Cancer Investigation · doi:10.3109/07357900903287006 · Cited by 119
Chemoprevention strategies for pancreatic cancer
Stan, S. D., Singh, S. V., & Brand, R. E. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.61 · Cited by 118
Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells
Ji, C., Cao, C., Lü, S., Kivlin, R., Amaral, A., KOUTTAB, N. M., Yang, H., Chu, W., Zhi-gang, B., Di, W. J., et al. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0674-6 · Cited by 118
NFκB inhibitors induce cell death in glioblastomas
Zanotto-Filho, A., Braganhol, E., Schröder, R., de Souza, L. H. T., Dalmolin, R. J. S., Pasquali, M. A. B., Gelain, D. P., Battastini, A. M. O., & Moreira, J. C. F. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.10.014 · Cited by 117
Dorai, T., Gehani, N., & Katz, A. E. (2000) · PubMed · Cited by 116
Jiang, M., Huang, O., Zhang, X., Xie, Z., Shen, A., Liu, H., Geng, M., & Shen, K. (2013) · Molecules · doi:10.3390/molecules18010701 · Cited by 116
Chakravarti, N., Myers, J. N., & Aggarwal, B. B. (2006) · International Journal of Cancer · doi:10.1002/ijc.21967 · Cited by 115
Chemopreventive and Chemotherapeutic Potential of Curcumin in Breast Cancer
Sinha, D., Biswas, J., Sung, B., Aggarwal, B. B., & Bishayee, A. (2012) · Current Drug Targets · doi:10.2174/138945012804545632 · Cited by 114
Huang, T., CHEN, Z., & FANG, L. (2012) · Oncology Reports · doi:10.3892/or.2012.2080 · Cited by 113
Cited by
Apoptosis: A Target for Anticancer Therapy
Pfeffer, C., & Singh, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020448 · Cited by 1,542
Loh, C.-Y., Chai, J., Tang, T., Wong, W., Sethi, G., Shanmugam, M., Chong, P., & Looi, C. (2019) · Cells · doi:10.3390/cells8101118 · Cited by 1,315
Self-citationGiordano, A., & Tommonaro, G. (2019) · Nutrients · doi:10.3390/nu11102376 · Cited by 1,000
The Role of Resveratrol in Cancer Therapy
Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122589 · Cited by 800
Self-citationNatural Polyphenols for Prevention and Treatment of Cancer
Zhou, Y., Zheng, J., Li, Y., Xu, D.-P., Li, S., Chen, Y.-M., & Li, H.-B. (2016) · Nutrients · doi:10.3390/nu8080515 · Cited by 746
Metadata
- Authors
- Shanmugam, M., Rane, G., Kanchi, M., Arfuso, F., Chinnathambi, A., Zayed, M., Alharbi, S., Tan, B., Kumar, A., & Sethi, G.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2015-02-05
- Volume
- 20
- Issue
- 2
- Pages
- 2728-2769
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2006901327
- Cited by
- 510
- References
- 283
- FWCI
- 18.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.